Earnings Call · Q2 FY2023·2023-01-26

Q2 23EPS +6.25%·Rev n/aQ1 23EPS 0.00%·Rev n/aQ4 22EPS +7.14%·Rev n/aQ3 22EPS -7.14%·Rev n/a⚠ consensus missing

RESMED INC RSMDF

Amy Wakeham — Vice President, Investor Relations

Mick Farrell — Chief Executive Officer

Brett Sandercock — Chief Financial Officer

+8.1%1d on move date+2.4% vs SPY3d−0.9%5d+4.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RSMDF calls or request research access.

More RSMDF calls Browse calls Request research access